What is the Impact Factor of Current Stem Cell Research & Therapy?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Current Stem Cell Research & Therapy is 2.10, ranking in quartile Q4 of Web of Science (SCIE).

Is Current Stem Cell Research & Therapy indexed in Web of Science or Scopus?

Yes, Current Stem Cell Research & Therapy is indexed in Web of Science (SCIE, Q4 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.538 (Q2) and an H-index of 67.

Who publishes Current Stem Cell Research & Therapy and what is the Article Processing Charge (APC)?

Current Stem Cell Research & Therapy is published by Bentham Science Publishers B.V.. The estimated Article Processing Charge (APC) is approximately $2,975 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Current Stem Cell Research & Therapy?

The official ISO-4 abbreviation of Current Stem Cell Research & Therapy is "CURR STEM CELL RES T" with common acronym "scrt". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q4Scopus Q2SCImago #11,038Review JournalHybrid

Current Stem Cell Research & Therapy

Acronym:scrt

•

Abbreviation (ISO):CURR STEM CELL RES T

•

Identifier (ISSN):1574-888X(Print)/2212-3946(Online)

•

Publisher:Bentham Science Publishers B.V.

Official Website Submission Portal Compare

Clarivate IF (2026)

2.1↓ -0.1

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Current Stem Cell Research & Therapy

WoS Q4

Annual Impact Factor Metric

Current (2026):2.1

Scopus SJR & RankScopus Q2

0.538

#11,038

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

67 papers with at least that number of citations each

WoS: SCIE / JCRQ4

Self-Citation Rate0%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

84articles/year

3.9% Gold OA•18.03% Original Research

Aims & Scope

Current Stem Cell Research & Therapy publishes high quality frontier reviews, drug clinical trial studies and guest edited issues on all aspects of basic research on stem cells and their uses in clinical therapy. The journal is essential reading for all researchers and clinicians involved in stem cells research.

Topics Covered (Recognized by AI)

Biology89.9%Genetics86.4%Medicine81.7%Cell biology81.4%Chemistry71.8%Biochemistry70%Stem cell69.6%Internal medicine62.6%Pathology58.4%Gene45.1%Mesenchymal stem cell39.3%Cell35.1%Surgery34.3%Immunology33.6%Psychology24.5%Cancer research24.2%In vitro24.1%Embryonic stem cell23.5%Regeneration (biology)23%Transplantation22.9%

Primary Research Areas

Cell & Tissue Engineering Cell Biology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

CELL & TISSUE ENGINEERING

Rank26/32

IndexSCIE

JCRSCIE2026

CELL BIOLOGY

Rank171/207

IndexSCIE

JCISCIE2026

CELL & TISSUE ENGINEERING

Rank30/32

IndexSCIE

JCISCIE2026

CELL BIOLOGY

Rank178/207

IndexSCIE

Category	Index	Rank	Quartile
CELL & TISSUE ENGINEERING	JCRSCIE	26/32	Q4
CELL BIOLOGY	JCRSCIE	171/207	Q4
CELL & TISSUE ENGINEERING	JCISCIE	30/32	Q4
CELL BIOLOGY	JCISCIE	178/207	Q4

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF2.1

Articles / Year37

Total Citations4

2025

IF2.2

Articles / Year54

Total Citations65

2024

IF2.1

Articles / Year83

Total Citations189

2023

IF2.7

Articles / Year117

Total Citations613

2022

IF3.758

Articles / Year140

Total Citations980

Year	Impact Factor	Articles / Year	Total Citations
2026	2.1	37	4
2025	2.2	54	65
2024	2.1	83	189
2023	2.7	117	613
2022	3.758	140	980
2021	3.828	93	873
2020	2.614	115	1,402
2019	2.612	80	1,524
2018	2.168	85	2,416
2017	—	68	2,000
2016	—	109	2,457
2015	—	65	1,096

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #11,038Scopus Q2SCImago Profile

Scopus Coverage:2006-2026

•

Scopus Broad Areas:Medicine

Scopus Citation Rank (SJR)Q2

0.538

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

2.39

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$2,975 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations680

3-Year Documents284

Citable Documents280

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate44.7%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Medicine (miscellaneous)Q2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Medicine

Minor Category (Specific Field):

4区CELL & TISSUE ENGINEERING

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Current Stem Cell Research & Therapy (acronym: scrt, abbr: CURR STEM CELL RES T, ISSN: 1574-888X) is a peer-reviewed international scholarly journal in the field of CELL & TISSUE ENGINEERING, published by Bentham Science Publishers B.V. in United Arab Emirates. The periodical holds a Journal Impact Factor (JIF) of 2.10, ranking in quartile Q4 of Web of Science (SCIE), a Scopus SJR indicator of 0.538 (Q2), an H-index of 67.

The journal enforces rigorous peer evaluation with an annual output of approximately 84 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $2,975 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.